Christian Lacks Lino Cardenas, Ph.D., Pharm.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth, Vascular | 5 | 2022 | 1621 | 1.510 |
Why?
|
| Aortic Aneurysm, Thoracic | 6 | 2022 | 627 | 1.350 |
Why?
|
| Alzheimer Disease | 4 | 2022 | 7259 | 0.870 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2011 | 431 | 0.790 |
Why?
|
| Transforming Growth Factor beta | 4 | 2022 | 1997 | 0.780 |
Why?
|
| Apolipoprotein E4 | 1 | 2022 | 618 | 0.680 |
Why?
|
| MicroRNAs | 7 | 2023 | 3680 | 0.660 |
Why?
|
| Virus Internalization | 1 | 2021 | 487 | 0.650 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2023 | 735 | 0.610 |
Why?
|
| Indazoles | 1 | 2018 | 293 | 0.590 |
Why?
|
| Histone Deacetylases | 2 | 2019 | 756 | 0.590 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 4 | 2019 | 436 | 0.580 |
Why?
|
| Estrogens | 1 | 2021 | 1529 | 0.520 |
Why?
|
| Drug Discovery | 1 | 2022 | 1071 | 0.480 |
Why?
|
| Pyridones | 1 | 2018 | 687 | 0.470 |
Why?
|
| Caveolin 1 | 2 | 2019 | 257 | 0.460 |
Why?
|
| DNA Helicases | 1 | 2018 | 827 | 0.450 |
Why?
|
| Repressor Proteins | 2 | 2019 | 3089 | 0.380 |
Why?
|
| Acyltransferases | 1 | 2010 | 306 | 0.350 |
Why?
|
| Marfan Syndrome | 2 | 2021 | 233 | 0.320 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 3 | 2011 | 331 | 0.310 |
Why?
|
| Aortic Aneurysm | 2 | 2022 | 668 | 0.310 |
Why?
|
| Amyloid beta-Peptides | 3 | 2022 | 3213 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 15600 | 0.250 |
Why?
|
| Muscle Contraction | 2 | 2019 | 1250 | 0.250 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2022 | 31 | 0.240 |
Why?
|
| Polymorphism, Genetic | 2 | 2010 | 4352 | 0.230 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5988 | 0.230 |
Why?
|
| Apolipoprotein E3 | 1 | 2022 | 92 | 0.220 |
Why?
|
| Fibroblasts | 4 | 2019 | 4286 | 0.220 |
Why?
|
| Tunicamycin | 1 | 2021 | 117 | 0.220 |
Why?
|
| Computational Biology | 2 | 2011 | 3568 | 0.210 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2022 | 155 | 0.210 |
Why?
|
| France | 3 | 2011 | 489 | 0.210 |
Why?
|
| Gene Frequency | 4 | 2011 | 3714 | 0.200 |
Why?
|
| Plants | 1 | 2022 | 302 | 0.200 |
Why?
|
| Connective Tissue Diseases | 1 | 2022 | 245 | 0.190 |
Why?
|
| Patents as Topic | 1 | 2022 | 144 | 0.190 |
Why?
|
| Enoxaparin | 1 | 2022 | 363 | 0.190 |
Why?
|
| Pericytes | 1 | 2022 | 262 | 0.180 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 371 | 0.180 |
Why?
|
| Peru | 1 | 2022 | 847 | 0.180 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 18353 | 0.180 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2022 | 312 | 0.180 |
Why?
|
| Muscle, Smooth | 1 | 2023 | 955 | 0.180 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2022 | 470 | 0.170 |
Why?
|
| Craniosynostoses | 1 | 2022 | 392 | 0.170 |
Why?
|
| Glycosylation | 1 | 2021 | 1138 | 0.170 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 3615 | 0.170 |
Why?
|
| Mice | 14 | 2022 | 81128 | 0.170 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 679 | 0.170 |
Why?
|
| Lung | 4 | 2013 | 9781 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2018 | 12073 | 0.160 |
Why?
|
| Actomyosin | 1 | 2018 | 112 | 0.160 |
Why?
|
| Histones | 2 | 2018 | 2588 | 0.160 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 850 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2022 | 2613 | 0.160 |
Why?
|
| Biological Transport | 1 | 2021 | 2136 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 6294 | 0.150 |
Why?
|
| Models, Molecular | 2 | 2021 | 5542 | 0.150 |
Why?
|
| Aorta | 3 | 2022 | 2114 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 1 | 2021 | 1098 | 0.150 |
Why?
|
| Losartan | 1 | 2018 | 265 | 0.150 |
Why?
|
| Animals | 16 | 2022 | 170894 | 0.140 |
Why?
|
| Bleomycin | 2 | 2017 | 512 | 0.140 |
Why?
|
| Mice, Knockout | 4 | 2019 | 15258 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 276 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2023 | 20097 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2011 | 6664 | 0.140 |
Why?
|
| Polysaccharides | 1 | 2021 | 994 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2020 | 841 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 817 | 0.130 |
Why?
|
| DNA Methylation | 2 | 2018 | 4102 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2023 | 10802 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2022 | 1158 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 2669 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2011 | 18738 | 0.120 |
Why?
|
| Genotype | 4 | 2011 | 12923 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 22929 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2018 | 4935 | 0.110 |
Why?
|
| tau Proteins | 1 | 2022 | 1645 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 1211 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2018 | 1235 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 1039 | 0.110 |
Why?
|
| Hypertension | 1 | 2011 | 8285 | 0.110 |
Why?
|
| Humans | 25 | 2022 | 717280 | 0.100 |
Why?
|
| IMP Dehydrogenase | 1 | 2010 | 35 | 0.100 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 1057 | 0.100 |
Why?
|
| Aneurysm, Dissecting | 1 | 2016 | 644 | 0.100 |
Why?
|
| Biocatalysis | 1 | 2011 | 181 | 0.100 |
Why?
|
| Cell Movement | 2 | 2014 | 5465 | 0.100 |
Why?
|
| Heparin | 1 | 2018 | 1637 | 0.100 |
Why?
|
| Acute Lung Injury | 1 | 2014 | 380 | 0.100 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2010 | 226 | 0.090 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2009 | 64 | 0.090 |
Why?
|
| Chemokines | 1 | 2014 | 960 | 0.090 |
Why?
|
| Smad Proteins | 2 | 2020 | 178 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 1730 | 0.090 |
Why?
|
| Base Sequence | 2 | 2011 | 13317 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 2918 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2018 | 3018 | 0.090 |
Why?
|
| RNA Interference | 1 | 2018 | 3020 | 0.090 |
Why?
|
| Aortic Valve | 1 | 2018 | 1835 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 14243 | 0.090 |
Why?
|
| Mitochondria | 1 | 2021 | 3642 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 1226 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2020 | 23997 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 2931 | 0.080 |
Why?
|
| Chromatin | 1 | 2018 | 2741 | 0.080 |
Why?
|
| DNA Primers | 1 | 2011 | 2999 | 0.070 |
Why?
|
| Phenotype | 3 | 2019 | 16404 | 0.070 |
Why?
|
| Mesoderm | 1 | 2009 | 729 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2010 | 2289 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 1276 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3471 | 0.070 |
Why?
|
| Mutation | 3 | 2018 | 29491 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3704 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1800 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2019 | 3262 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3991 | 0.060 |
Why?
|
| Male | 10 | 2022 | 351399 | 0.060 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 1603 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2011 | 1751 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2013 | 4356 | 0.060 |
Why?
|
| RNA, Nuclear | 1 | 2022 | 27 | 0.060 |
Why?
|
| Cell Line | 1 | 2018 | 16693 | 0.060 |
Why?
|
| Fibrillar Collagens | 1 | 2022 | 40 | 0.060 |
Why?
|
| Binding Sites | 1 | 2011 | 6295 | 0.060 |
Why?
|
| Pandemics | 1 | 2022 | 7292 | 0.050 |
Why?
|
| Actinin | 1 | 2022 | 163 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2511 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2022 | 317 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2022 | 516 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17432 | 0.050 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2020 | 79 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 12435 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 4916 | 0.050 |
Why?
|
| Gene Expression | 1 | 2013 | 8013 | 0.050 |
Why?
|
| Cytokines | 1 | 2014 | 7223 | 0.040 |
Why?
|
| Alleles | 1 | 2010 | 7101 | 0.040 |
Why?
|
| Protein Binding | 1 | 2011 | 9665 | 0.040 |
Why?
|
| Siblings | 1 | 2022 | 820 | 0.040 |
Why?
|
| Heart Failure | 1 | 2021 | 10185 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2017 | 3094 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2019 | 224 | 0.040 |
Why?
|
| Female | 9 | 2022 | 377934 | 0.040 |
Why?
|
| Nitrophenols | 1 | 2017 | 175 | 0.040 |
Why?
|
| Brain | 2 | 2022 | 25281 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 496 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11762 | 0.030 |
Why?
|
| Aging | 1 | 2014 | 8376 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1692 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 945 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 2031 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 2834 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 681 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 11951 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 3532 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 2001 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 2935 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2010 | 137 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 1976 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2021 | 4589 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1729 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2020 | 2974 | 0.020 |
Why?
|
| Zebrafish | 1 | 2018 | 3030 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2019 | 39891 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 2593 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3433 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13613 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2021 | 8582 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2010 | 1323 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3993 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6753 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16989 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2013 | 3514 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2022 | 24744 | 0.010 |
Why?
|
| Wound Healing | 1 | 2014 | 2800 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 13301 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 51277 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3694 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 215054 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 212470 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 19537 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 13716 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 70863 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 162862 | 0.000 |
Why?
|